← FDA DRUG APPROVALS

FDA ANDA · ANDA204867

PREDNISONE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA204867
TYPE
ANDA
ORIGINAL APPROVAL
2017-04-25
LATEST ACTION
2017-04-25
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

PREDNISONEDiscontinued
PREDNISONE 5MG · TABLET, DELAYED RELEASE · ORAL
PREDNISONEDiscontinued
PREDNISONE 1MG · TABLET, DELAYED RELEASE · ORAL
PREDNISONEDiscontinued
PREDNISONE 2MG · TABLET, DELAYED RELEASE · ORAL

Approval history

2017-04-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →